
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES145
The INVEST study found NS difference in the treatments (verapamilvSR and atenolol) for
death or first occurrence of non-fatal MI or non-fatal stroke in both the diabetic and nondiabetic
groups.259 Level 1+

[@Lindholm_2002]

